APT Medical Inc. (SHA:688617)
China
· Delayed Price · Currency is CNY 231.50
+4.49 (1.98%)
Mar 10, 2026, 3:00 PM CST
APT Medical Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2017 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2017 |
| Operating Revenue | 2,584 | 2,049 | 1,642 | 1,204 | 822.86 | Upgrade
|
| Other Revenue | - | 16.62 | 8.49 | 11.55 | 5.82 | Upgrade
|
| Revenue | 2,584 | 2,066 | 1,650 | 1,216 | 828.69 | Upgrade
|
| Revenue Growth (YoY) | 25.08% | 25.18% | 35.71% | 46.74% | 72.85% | Upgrade
|
| Cost of Revenue | - | 579.89 | 486.14 | 354.04 | 259.08 | Upgrade
|
| Gross Profit | 2,584 | 1,486 | 1,164 | 861.98 | 569.61 | Upgrade
|
| Selling, General & Admin | - | 464.34 | 386.96 | 307.57 | 251.43 | Upgrade
|
| Research & Development | - | 290.54 | 237.92 | 174.88 | 134.88 | Upgrade
|
| Other Operating Expenses | 1,640 | 15.22 | 14.52 | 13.75 | 8.14 | Upgrade
|
| Operating Expenses | 1,640 | 772.32 | 639.21 | 496.99 | 393.93 | Upgrade
|
| Operating Income | 943.93 | 713.59 | 524.86 | 364.99 | 175.68 | Upgrade
|
| Interest Expense | - | -2.01 | -3.69 | -1.45 | -1.63 | Upgrade
|
| Interest & Investment Income | - | 25.23 | 27.74 | 23.94 | 13.26 | Upgrade
|
| Currency Exchange Gain (Loss) | - | 2.83 | 2.66 | 1.17 | -1 | Upgrade
|
| Other Non Operating Income (Expenses) | -7.64 | -0.82 | -0.04 | -0.49 | -0.5 | Upgrade
|
| EBT Excluding Unusual Items | 936.29 | 738.83 | 551.53 | 388.16 | 185.81 | Upgrade
|
| Impairment of Goodwill | - | - | -3.84 | - | - | Upgrade
|
| Gain (Loss) on Sale of Investments | - | -16.7 | - | 0.34 | 21.72 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | 0.25 | 11.97 | 0.06 | 0.02 | Upgrade
|
| Asset Writedown | - | -0.83 | -0.12 | -10.68 | -3.57 | Upgrade
|
| Other Unusual Items | - | 24.42 | 36.83 | 17.25 | 17.58 | Upgrade
|
| Pretax Income | 936.29 | 745.97 | 596.37 | 395.13 | 221.55 | Upgrade
|
| Income Tax Expense | 115.65 | 87.8 | 74.24 | 54.98 | 26.7 | Upgrade
|
| Earnings From Continuing Operations | 820.64 | 658.17 | 522.13 | 340.16 | 194.85 | Upgrade
|
| Minority Interest in Earnings | - | 14.98 | 11.79 | 17.86 | 13.07 | Upgrade
|
| Net Income | 820.64 | 673.15 | 533.92 | 358.02 | 207.92 | Upgrade
|
| Net Income to Common | 820.64 | 673.15 | 533.92 | 358.02 | 207.92 | Upgrade
|
| Net Income Growth | 21.91% | 26.08% | 49.13% | 72.19% | 87.70% | Upgrade
|
| Shares Outstanding (Basic) | 141 | 140 | 140 | 140 | 137 | Upgrade
|
| Shares Outstanding (Diluted) | 141 | 141 | 142 | 142 | 138 | Upgrade
|
| Shares Change (YoY) | -0.03% | -0.52% | -0.16% | 2.99% | 31.45% | Upgrade
|
| EPS (Basic) | 5.82 | 4.80 | 3.82 | 2.56 | 1.52 | Upgrade
|
| EPS (Diluted) | 5.82 | 4.77 | 3.77 | 2.52 | 1.51 | Upgrade
|
| EPS Growth | 21.95% | 26.74% | 49.38% | 67.20% | 42.79% | Upgrade
|
| Free Cash Flow | - | 93.15 | 487.03 | 224.25 | 14.01 | Upgrade
|
| Free Cash Flow Per Share | - | 0.66 | 3.44 | 1.58 | 0.10 | Upgrade
|
| Dividend Per Share | - | 1.207 | 0.951 | 0.785 | 0.476 | Upgrade
|
| Dividend Growth | - | 26.88% | 21.20% | 65.01% | 100.00% | Upgrade
|
| Gross Margin | 100.00% | 71.93% | 70.54% | 70.88% | 68.74% | Upgrade
|
| Operating Margin | 36.53% | 34.54% | 31.81% | 30.01% | 21.20% | Upgrade
|
| Profit Margin | 31.76% | 32.58% | 32.36% | 29.44% | 25.09% | Upgrade
|
| Free Cash Flow Margin | - | 4.51% | 29.51% | 18.44% | 1.69% | Upgrade
|
| EBITDA | 1,021 | 790.25 | 580.9 | 405.69 | 203.49 | Upgrade
|
| EBITDA Margin | 39.50% | 38.25% | 35.20% | 33.36% | 24.56% | Upgrade
|
| D&A For EBITDA | 76.66 | 76.66 | 56.04 | 40.7 | 27.81 | Upgrade
|
| EBIT | 943.93 | 713.59 | 524.86 | 364.99 | 175.68 | Upgrade
|
| EBIT Margin | 36.53% | 34.54% | 31.80% | 30.01% | 21.20% | Upgrade
|
| Effective Tax Rate | 12.35% | 11.77% | 12.45% | 13.91% | 12.05% | Upgrade
|
| Revenue as Reported | - | 2,066 | 1,650 | 1,216 | 828.69 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.